Clarifying Optimal Sodium InTake In Cardiovasular and Kidney (COSTICK) Diseases: a study protocol for two randomised controlled trials [version 2; peer review: 2 approved, 1 approved with reservations]

Clarifying Optimal Sodium InTake In Cardiovasular and Kidney (COSTICK) Diseases: a study protocol for two randomised controlled trials [version 2; peer review: 2 approved, 1 approved with reservations]

Background: While low sodium intake (<2.3g/day) is recommended for all, there is uncertainty about feasibility and net cardiovascular effects. In COSTICK, we evaluated the effects of a dietary counselling intervention (reduced sodium intake) on intermediate cardiorenal outcomes in patients with (...

Full description

Bibliographic Details
Main Authors: Alberto Alvarez-Iglesias, Claire Kerins, Salim Yusuf, Roisin Dineen, Aoife Nolan, Colette Corcoran, Suzanne McDermott, Andrew Smyth, John Ferguson, Ritika Ranjan, Orlaith Hernon, Martin O'Donnell, Paula O'Shea, Matthew Griffin, Michelle Canavan
Format: Article
Language:English
Published: F1000 Research Ltd 2022-02-01
Series:HRB Open Research
Subjects:
Cardiovascular Disease
Chronic Kidney Disease
Sodium Reduction
Renal Insufficiency
Biomarkers
Clinical Trial
eng
Online Access:https://hrbopenresearch.org/articles/4-14/v2

Internet

https://hrbopenresearch.org/articles/4-14/v2

Similar Items